Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Fan

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Molecular and Cellular Cardiology|April 8, 2018
Corrigendum to "Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation" [J. Mol. Cell. Cardiol. 117 (2018) 88-99]Amanda Soler, Ian Hunter, Gregory Joseph, et al.
Journal of Molecular and Cellular Cardiology|February 12, 2018
Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activationAmanda Soler, Ian Hunter, Gregory Joseph, et al.
Pain Research & Management|March 2, 2026
Biomechanical Comparisons of Two Types of Tuina in Treating Lumbar Disc Herniation: A Finite Element AnalysisFrank Fan Huang, Ming-Wang Qiu, Wan-Ming Wu, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureusFrank Fan, Kang Yan, Nicola G Wallis, et al.
Circulation|December 28, 2018
One-Year Outcomes After MitraClip for Functional Mitral RegurgitationGorav Ailawadi, D Scott Lim, Michael J Mack, et al.
Journal of Molecular Microbiology and Biotechnology|March 27, 2004
A global approach to identify novel broad-spectrum antibacterial targets among proteins of unknown functionMagdalena Zalacain, Sanjoy Biswas, Karen A Ingraham, et al.
ACS Chemical Biology|August 17, 2012
Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrateMary P Hall, James Unch, Brock F Binkowski, et al.
Plos One|June 19, 2013
Imaging proteolytic activity in live cells and animal modelsStefanie Galbán, Yong Hyun Jeon, Brittany M Bowman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2020
U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid TumorsKyriakos P Papadopoulos, Erkut Borazanci, Alice T Shaw, et al.
Journal of Medical Case Reports|December 10, 2022
Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case reportBai-Yan Wang, Wan-Hong Zhao, Yin-Xia Chen, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Molecular and Cellular Cardiology|April 8, 2018
Corrigendum to "Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation" [J. Mol. Cell. Cardiol. 117 (2018) 88-99]Amanda Soler, Ian Hunter, Gregory Joseph, et al.
Journal of Molecular and Cellular Cardiology|February 12, 2018
Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activationAmanda Soler, Ian Hunter, Gregory Joseph, et al.
Pain Research & Management|March 2, 2026
Biomechanical Comparisons of Two Types of Tuina in Treating Lumbar Disc Herniation: A Finite Element AnalysisFrank Fan Huang, Ming-Wang Qiu, Wan-Ming Wu, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureusFrank Fan, Kang Yan, Nicola G Wallis, et al.
Circulation|December 28, 2018
One-Year Outcomes After MitraClip for Functional Mitral RegurgitationGorav Ailawadi, D Scott Lim, Michael J Mack, et al.
Journal of Molecular Microbiology and Biotechnology|March 27, 2004
A global approach to identify novel broad-spectrum antibacterial targets among proteins of unknown functionMagdalena Zalacain, Sanjoy Biswas, Karen A Ingraham, et al.
ACS Chemical Biology|August 17, 2012
Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrateMary P Hall, James Unch, Brock F Binkowski, et al.
Plos One|June 19, 2013
Imaging proteolytic activity in live cells and animal modelsStefanie Galbán, Yong Hyun Jeon, Brittany M Bowman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2020
U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid TumorsKyriakos P Papadopoulos, Erkut Borazanci, Alice T Shaw, et al.
Journal of Medical Case Reports|December 10, 2022
Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case reportBai-Yan Wang, Wan-Hong Zhao, Yin-Xia Chen, et al.
Pageof 6